SEARCH

SEARCH BY CITATION

References

  • 1
    Ader M, Bergman RN. Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. Am J Physiol 1990; 258(6 Pt 1): E10201032.
  • 2
    Edgerton D, Lautz M, Scott M et al. Insulin's direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest 2006; 116: 521527.
  • 3
    Marks JS, Botelho LH. Synergistic inhibition of hepatic glycogenolysis in the presence of insulin and a cAMP antagonist. J Biol Chem 1986; 261: 27812785.
  • 4
    Claus TH, Pilkis SJ. Regulation by insulin of gluconeogenesis in isolated rat hepatocytes. Biochim Biophys Acta 1976; 421: 246262.
  • 5
    Girard J. The inhibitory effects of insulin on hepatic glucose production are both direct and indirect. Diabetes 2006; 55(Suppl. 2): S6569.
  • 6
    Pagotto U. Where does insulin resistance start?: The brain. Diabetes Care 2009; 32(Suppl. 2): S174177.
  • 7
    Ekberg K, Landau B, Wajngot A et al. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes 1999; 48: 2928.
  • 8
    Bergman R. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? Diabetologia 2000; 43: 946952.
  • 9
    Chap Z, Ishida T, Chou J et al. First-pass hepatic extraction and metabolic effects of insulin and insulin analogues. Am J Physiol 1987; 252(2 Pt 1): E209217.
  • 10
    Chan S, Steiner D. Insulin through the ages: phylogeny of a growth promoting and metabolic regulatory hormone. Am Zool 2000; 40: 213222.
  • 11
    Nagamatsu S, Chan S, Falkmer S, Steiner D. Evolution of the insulin gene superfamily sequence of a preproinsulin-like growth factor cDNA from the atlantic Hagfish. J Biol Chem 1991; 266: 23972402.
  • 12
    Pierce SB. Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev 2001; 15: 672686.
  • 13
    Conlon J. Molecular evolution of insulin in non-mammalian vertebrates. Am Zool 2000; 40: 200212.
  • 14
    Peterson J, Steiner D. The amino acid sequence of the insulin from a primitive vertebrate, the Atlantic hagfish (Myxine glutinosa). J Biol Chem 1975; 250: 51855191.
  • 15
    Sajid W, Holst PA, Kiselyov VV et al. Structural basis of the aberrant receptor binding properties of hagfish and lamprey insulins. Biochemistry 2009; 48: 1128311295.
  • 16
    Simon J, Freychet P, Bosselin G, DeMeyts P. Enhanced binding affinity of chicken insulin in rat liver membranes and human lymphocytes: relationship to the kinetic properties of the hormone- receptor interaction. Endocrinology 1977; 100: 115121.
  • 17
    Muggeo M, Ginsberg B, Roth J, Neville D, Pierre de Meyts J, Ronald Kahn C. The insulin receptor in vertebrates is functionally more conserved during evolution than insulin itself. Endocrinology 1979; 104: 13931402.
  • 18
    Jones R, Dron D, MJ E, PH S, Brandenberg D. Biological properties of chemically modified insulins. I. Biological activity of proinsulin and insulin modified at A1-glycine and B29-lysine. Diabetologia 1976; 12: 601608.
  • 19
    Parton M. Blood flow in the liver of the dosmestic fowl. J Anat 1970: 189.
  • 20
    Akester A. Radiographic studies of the renal portal system in the domestic fowl (Gallus domesticus). J Anat 1964; 98: 365763.
  • 21
    Gerich JE. Control of glycaemia. Baillieres Clin Endocrinol Metab 1993; 7: 551586.
  • 22
    Gottesman I, Mandarino L, Gerich J. Estimation and kinetic analysis of insulin-independent glucose uptake in human subjects. Am J Physiol 1983; 244: E632635.
  • 23
    Hall S, Saunders J, PH S. Glucose and free fatty acid turnover in normal subjects and in diabetic patients before and after insulin treatment. Diabetologia 1979; 16: 297306.
  • 24
    Hordern SVM, Wright JE, Umpleby AM, Shojaee Moradie F, Amiss J, Russell-Jones DL. Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp. Diabetologia 2005; 48: 420426.
  • 25
    Sonksen PH, Russell-Jones D, Jones RH. Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future? Horm Res 1993; 40(1–3): 6879.
  • 26
    Shojaee-Moradie F, Powrie JK, Sundermann E et al. Novel hepatoselective insulin analog. Studies with a covalently linked thyroxyl-insulin complex in humans. Diabetes Care 2000; 23: 11241129.
  • 27
    Logtenberg SJ, Kleefstra N, Houweling ST et al. Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial. Diabetes Care 2009; 32: 13721377.
  • 28
    Radziuk J, Barron P, Najm H, Davies J. The effect of systemic venous drainage of the pancreas on insulin sensitivity in dogs. J Clin Invest 1993; 92: 11731721.
  • 29
    Simpson HL. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. J Clin Endocrinol Metabol 2004; 89: 425432.
  • 30
    Saudek CD, Selam JL, Pitt HA et al. Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. N Engl J Med 1989; 321: 574579.
  • 31
    Selem J, Kashyap M, Alberti K et al. Comparison of intraperitoneal and subcutaneous insulin administration on lipids. Metabolism 1989: 908912.
  • 32
    Duckworth WC, Saudek CD, Henry RR. Why intraperitoneal delivery of insulin with implantable pumps in NIDDM? Diabetes 1992; 41: 657661.
  • 33
    Osama Gaber A, Shokouh-Amiri H, Hathaway D et al. Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg 1995; 221: 613622.
  • 34
    Shapiro J. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 13181330.
  • 35
    Dieken M, Federwisch M, De Meyts P. In: Dieken M, Federwisch M, De Meyts P, eds. Insulin & Related Proteins: Structure to Function and Pharmacology. Relationship between the structure of insulin and its physiological effect. Dordrecht: Kluwer Academic Publishers, 2002; 121130.
  • 36
    Sonksen PH, Tompkins CV, Srivastava MC, Nabarro JD. A comparative study on the metabolism of human insulin and porcine proinsulin in man. Clin Sci Mol Med 1973; 45: 633654.
  • 37
    Revers RR, Henry R, Schmeiser L et al. The effects of biosynthetic human proinsulin on carbohydrate metabolism. Diabetes 1984; 33: 762770.
  • 38
    Shojaee Moradie F, Jackson N, Boroujerdi M, Sonksen PH, Jones RH. Demonstration of a relatively hepatoselective effect of covalent insulin dimers on glucose metabolism in dogs. Diabetologia 1995; 38: 10071013.
  • 39
    Shojaee-Moradie F, Michelle C, Micayla T et al. Effect of thyroid hormone binding proteins on insulin receptor binding of B1-thyronine-insulin analogues. Biochem J 2004; 10: 5157.
  • 40
    Shojaee Moradie F, Eckey H, Jackson NC et al. Novel hepatoselective insulin analogues: studies with covalently linked thyroxyl-insulin complexes. Diabet Med 1998; 15: 928936.
  • 41
    Kurtzhals P, Havelund S, Jonassen I et al. Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J 1995; 312: 725731.
  • 42
    Smeeton F, Shojaee Moradie F, Jones RH et al. Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes. Diabetologia 2009; 52: 23172323.
  • 43
    Zachariah S, Sheldon B, Shojaee-Moradie F et al. Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes. Diabetes Care 2011; 34: 14871491.
  • 44
    Birkeland K, Home PD, Wendisch U et al. Insulin degludec in type 1 diabetes a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine. Diabetes Care 2011; 34: 661668.
  • 45
    Courtney Moore M, Smith M, Mace K et al. Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism. Phildelphia: Annual American Diabetes Association Conference, 2012.
  • 46
    Bergenstal R, Rosenstock J, Arakaki R et al. A randomised, controlled study of once daily LY2605541, a novel long acting basal insulin versus insulin treated patients with type 2 diabetes. Diabetes Care 2012; 35: 21402147.
  • 47
    Edgerton D, Scott M, Roop J et al. Effect of peripheral delivery of a liver preferential insulin analog on glucose and fat metabolism. Diabetes 2012; 61: A92 (Abstract 352-P).
  • 48
    Chap Z, Jones RH, Chou J, Hartley CJ, Entmen ML. Effect of dexamethasone on hepatic glucose and insulin metabolism after oral glucose in conscious dogs. J Clin Invest 1986; 78: 13351361.